JCR Pharmaceuticals Co., Ltd. announced change of Corporate Officers. Junichi Ando, Ph.D.: new title: Corporate Officer Executive Director, Quality Assurance Division; current title: Director, Kobe Plant Production Division. Yutaka Honda: new title: Corporate Officer Executive Director, Administration Division (reporting to the president); current title: Senior Corporate Officer Director, Office of the President Executive Director, Corporate Planning Division. Akihiro Haguchi: new title: Senior Advisor, Administration Division; current title: Senior Corporate Officer Executive Director, Administration Division. Katsuya Daimon, Ph.D.: new title: Director, Regulatory Affairs Dept. Quality Assurance Division and Manager, Regulatory Affairs Office and Manager Regulatory Audit Office; current title: Director, Regulatory Affairs Dept. and Manager, Regulatory Affairs Office and Manager, Regulatory Audit Office. Mariko Okada: new title: Director, Pharmacovigilance Dept. Quality Assurance Division; current title: Director, Pharmacovigilance Dept. Toshiya Tomitsuka: new title: Director, HQ Quality Assurance Dept. Quality Assurance Division; current title: Director, HQ Quality Assurance Dept. and Director, Quality Assurance Dept. Production Division. Hironori Yamaguchi: new title: Senior Director, Sales Division and Director, Sales Promotion Dept.; current title: Senior Director, Sales Division. Kazuhiro Koabayashi: new title: Director, GH Promotion Dept. Sales Division; current title: Director, Sales Promotion Dept. Sales Division. Makoto Ashida: new title: Senior Director, Production Division and Corporate Strategy Dept. (Production); current title: Director, Production Planning Dept. Production Division and Director, Human Resources Dept. Administration Division. Kenji Isokawa: new title: Director, Seishin Production Unit, Production Division; current title: Director, Seishin Plant Production Division. Yukihiro Kuromoto: new title: Director, Murotani API Unit, Production Division; current title: Director, Murotani Plant Production Division. Yasushi Zenitani: new title: Director, Kobe API Unit, Production Division; current title: Director, Kobe API Plant Production Division. Kenichi Takahashi, Ph.D.: new title: Scientific Expert Fellow, Research Division and Director, Innovative Technology Research Institute; current title: Scientific Expert Fellow, Research Division and Director, Biopharmaceutical Innovation Research Unit, Drug Discovery Research Institute. Toru Hirato, D.V.M: new title: Director, Drug Discovery Research Institute Research Division; current title: Senior Fellow, Research Division. Kazutoshi Mihara: new title: Director, CMC Development Research Institute; current title: Director, CMC Development Research Institute and Manager, Bioprocess Unit. Yasuki Hamazume, Ph.D.: new title: Director, Analytical R&D center, Research Division; current title: Fellow, Research Division. Naoki Kawata: new title: Director, Corporate Strategy Dept.; current title: Director, Corporate Planning Division (Corporate Planning). Masaaki Usui: new title: Director, Global Business Strategy Dept.; current title: Director, Corporate Planning Division (Product & Portfolio Strategy). Hiroshi Kagoshige: new title: Director, Business Development Dept.; current title: Associate Director, Corporate Planning Division (Business Development). Hiroyuki Fukuya: new title: Director, Legal Affairs Dept. Administration Division; current title: Director, Legal Affairs Dept. Corporate Planning Division. Yoshiki Yamamoto: new title: Director, Intellectual Property Dept. Administration Division; current title: Director, Intellectual Property Dept. Corporate Planning Division. Masaki Sumiyoshi: new title: Director, Human Resource Planning Dept.; current title: Senior Director, Administration Division and Director, Human Resources Dept. Takanori Nakajima: new title: Director, Internal Control Dept.; current title: Director, HR Development & Compliance Dept. Administration Division. Yoshihiro Ota: new title: Director, Accounting Department and Corporate Strategy Dept. (Finance); current title: Director, Accounting Dept. Administration Division. Effective date is June 23, 2021.
JCR Pharmaceuticals Co., Ltd. is a Japan-based company primarily engaged in the pharmaceutical business, as well as the medical and research equipment business. The Company operates in two segments. The Pharmaceutical segment engages in the research, production, purchase and sale of medical drugs and pharmaceutical raw materials. The Medical and Research Equipment segment engages in the purchase and sale of the medical and research equipment.